Aim: To compare the dosimetric advantage of stereotactic body radiotherapy (SBRT) for localized lung tumor between deep inspiration breath hold technique and free breathing technique. Materials and methods: We retrospectively included ten previously treated lung tumor patients in this dosimetric study. All the ten patients underwent CT simulation using 4D-CT free breathing (FB) and deep inspiration breath hold (DIBH) techniques. Plans were created using three coplanar full modulated arc using 6 MV flattening filter free (FFF) bream with a dose rate of 1400 MU/min. Same dose constraints for the target and the critical structures for a particular patient were used during the plan optimization process in DIBH and FB datasets. We intend to deliver 50 Gy in 5 fractions for all the patients. For standardization, all the plans were normalized at target mean of the planning target volume (PTV). Doses to the critical structures and targets were recorded from the dose volume histogram for evaluation. Results: The mean right and left lung volumes were inflated by 1.55 and 1.60 times in DIBH scans compared to the FB scans. The mean internal target volume (ITV) increased in the FB datasets by 1.45 times compared to the DIBH data sets. The mean dose followed by standard deviation (x̄ ± σ x̄) of ipsilateral lung for DIBH-SBRT and FB-SBRT plans were 7.48 ± 3.57 (Gy) and 10.23 ± 4.58 (Gy) respectively, with a mean reduction of 36.84% in DIBH-SBRT plans. Ipsilateral lung were reduced to 36.84% in DIBH plans compared to FB plans. Conclusion: Significant dose reduction in ipsilateral lung due to the lung inflation and target motion restriction in DIBH-SBRT plans were observed compare to FB-SBRT. DIBH-SBRT plans demonstrate superior dose reduction to the normal tissues and other critical structures.
Introduction
Organ motion management in radiotherapy has evolved in last few decades along with technology development. Stereotactic body radiation therapy (SBRT) requires precise delineation of patient anatomy, targets for planning, and clear visualization for localization during treatment delivery [1] . SBRT became a standard care of treatment for early stage lung cancer patients who are not fit for surgery [2] . In SBRT, precise delineation and localization of target is vital for an effective treatment. SBRT methodology is to deliver a highly conformal ablative dose to the tumor in a hypo-fractionation radiation schedule. SBRT requires biological equivalent dose (BED) ≥ 100 Gy to achieve a tumor control of 85% irrespective of the tumor size in the primary and metastatic lung [3] . To safely practice SBRT, we need to follow stringent criteria starts from immobilization, delineation, treatment planning to treatment delivery. Motion management in moving organ is an important step in the SBRT treatment process, precious localization of the tumor during the target delineation and treatment delivery has to be in a high confidence level. To obtain the high confidence level, we need to have a clear idea about utilizing the available imaging technique to incorporate the tumor motion. International commission on Radiation Units and measurements (ICRU) report no 62 (Supplement to ICRU Report 50): Prescribing, Recording, and Reporting Photon Beam Therapy released in 1999 [4] recommended a term Internal Target Volume (ITV) in the moving tumors. ITV is described as a clinical target volume (CTV) with additional margin which encompass the tumor motion. Determination of accurate ITV become mandatory in SBRT; 4-dimensional computed tomography (4DCT) which is the combination of the 3D data of different respiratory phases enable us to determine the ITV. The maximum intensity projection (MIP) data set derived from all the respiratory phases become the standard golden data set for ITV delineation. There are different approach used by several authors Rosenzweig et al. [5] used deep inspiration breath hold (DIBH) technique where lung tumor can immobilized at a particular position and radiation field will be the smallest, hence using DIBH they can escalate the average from dose from 69.4 Gy to 87.9 Gy, without increasing the risk of toxicity. In this dosimetric study we try to investigate the dosimetric advantages of DIBH-SBRT compared to the FB-SBRT.
Materials and methods
We retrospectively selected ten previously treated localized lung cancer patients stage (T1/T2, N0, M0) in this study. Out of the ten patients two patients were treated with deep inspiration breath hold technique and remaining eight patients treated with free breathing technique using 4D-CT. All the patients were underwent CT simulation with both 4-dimensional Computed Tomography (4D-CT) and deep inspiration breath hold. The patient's demographic data were listed below in the Table 1 .Ten patients with mean age of 54.7 years (range, 44 to 67 years) were retrospectively included in this study from our previously treated SBRT patient record. Out of ten patients six were right sided and four were left sided lung tumors. Among the ten patients six were male (four out of six were smokers) and four were female. The selected lung patients were mostly peripheral localized lung tumor, mostly had co-morbidities (i.e., COPD, Hypertension, etc.,) and not fit for surgery. The gender, age, stage and the location of the primary tumor along with the co-morbidities were listed in the Table 1. 
CT simulation
All the patients were immobilized with custom made vacloc (M/S Civco, USA) fixed with 'T' shaped wing board indexed to the couch. A computed tomography (CT) with a slice thickness of 2.5 mm was obtained for all the patients using GE Discovery 600 16-slice PET-CT scanner. Varian real time position management (RPM) equipped with infra-red camera and 6 dot reflective markers, which are integrated with the GE CT was used for all the patients to obtain the DIBH scans and 4D-CT scans. DIBH scans were acquired by helical mode, with 2.5 mm slice thickness, 16 rows detectors, 20 sec breath hold, 400 mm field of view and without any inter slice gap. All the patients were evaluated for the compliance of ability to hold the breath for 20 sec. Prior to the DIBH scan, the patients were explained, coached, and assessed the upper and lower threshold cut off for all the patients. During the breath hold scan the upper and lower threshold cut off were set and documented.
During the simulation three sets of DIBH scans were taken for a patient to determine the ITV for the DIBH dataset. The 4DCT scans were acquired using a cine mode acquisition, with 2.5 mm slice thickness, 8 row detectors, 400 mm field of view, cine acquisition duration (breathing period of the individual patient + 0.5 sec), cine acquisition gap 0.45 sec and without any inter slice gap. Once the cine acquisition completed the breath pattern with CT data acquisition information file was automatically transfer from the RPM system to the CT console. Using this file the cine acquisition data were divided into ten bins of respiratory phases (CT0, CT10, CT20, CT 30, CT40, CT50, CT60, CT70, CT80 and CT90). From the ten respiratory bins the MIP and the average intensity projection (AveIP) were also derived for all the patients. Figure 1 shows the DIBH and FB datasets, which clearly illustrates the lung inflation and reduced GTV volume. Once the patient CT data acquired, the CT images were imported into Eclipse treatment planning system, Ver. 11.0 (M/S Varian Medical Systems, Palo Alto, CA, USA). The body structure was segmented automatically by the treatment planning system. 
Critical structures contouring
All the critical structures were contoured as per the RTOG 0915 report [6] guidelines. The spinal cord has been contoured in every slice, starting at least 10 cm above the superior extend of the PTV and finish at least 10 cm below the inferior extend of the PTV. Mediastinal window level was set on the planning CT to delineate the esophagus slice by slice, starting at least 10 cm above the superior extend of the PTV and finish at least 10cm below the inferior extend of the PTV. The Heart was contoured beside the pericardial sac; the superior landmarks were the level of the inferior aspects of aortic arch and inferiorly extend up to the apex of the heart. Trachea and main bronchus which include the entire trachea, carina and proximal bronchial tree were delineated as a single structure. Both the right and left lungs has been contoured separately to estimate the dosimetric advantage in the ipsilateral lung between the DIBH and FB technique. Contouring has been carried out using pulmonary windows. All inflated and collapsed lung has been included in this structures. The pulmonary trunk delineated from the anterior and medial wall of the right atrium, overlaps root of aorta and include the right and left pulmonary arteries. A 3D view of the all the critical structures and the target were illustrated in the 
Target delineation
4DCT MIP datasets were used for the internal target volume delineation in the free breathing mode and they were verified by running the cine mode of the 10 phases CT data sets to ensure the target is inside the delineated ITV from the MIP data sets. We have acquired three DIBH data sets with common Dicom origin during the CT simulation process to include the uncertainty of the target within the upper and the lower threshold of the deep inspiration breath hold. The ITV was derived by delineating the target in all the three datasets which were shared a common Dicom origin as shown in the Figure 3 . Both the DIBH and FB ITV's were expanded with 4 mm 3-dimensional margin to obtain the PTV.
Treatment planning and optimization
Eclipse treatment planning system (Varian Medical Systems, USA) was used for SBRT treatment planning for both DIBH and FB techniques. All the SBRT plans were planned with coplanar volumetric modulated arc therapy (VMAT) technique with 3 complete arcs. TrueBeam linear accelerator (Varian Medical Systems, USA) with 6 MV flattening filter free beam (FFF) using Millennium -120 multi-leaf collimator were used in all the plans. The DIBH-SBRT plans were done in DIBH CT datasets whereas FB-SBRT plans were done in the 4D-CT (AveIP) data sets. Progressive resolution optimization algorithm ver. 11.0 was used for the VMAT optimization. Dose calculation of both DIBH-SBRT and FB-SBRT plans were calculated using analytical anisotropic algorithm (AAA) ver.11.0. All the patients were planned to deliver 50 Gy in 5 fractions to the PTV. The dose constraints for a particular patient were kept identical during the optimization process for both DIBH-SBRT and FB-SBRT plan. To standardization the treatment plans, all the plans were normalized to the target mean of the PTV. 
Plan evaluation
In the report ICRU report 83 [7] , prescribing, recording and reporting photon beam intensity-modulated radiation therapy describes the dose homogeneity and dose conformity are independent specifications of the quality of the absorbed dose distribution. Dose homogeneity characterizes the uniformity of the absorbed-dose distribution within the target volume. Dose conformity characterizes the degree to which the high-dose region conforms to the target volume, usually the PTV. 
Homogeneity index (HI)
%
Conformity index (CI)
In 1993, Radiation Therapy Oncology Group recommended CI as a ratio of the reference isodose volume to the target volume.
TV V CI
Where, V RI reference isodose volume, and TV is the target volume (i.e., PTV). Figure 6 illustrates the example of computing the conformity index, for example if the PTV volume is 100 cc, where your reference isodose line (if the prescription is 50 Gy, your reference isodose is 95%, 47.5 Gy volume will be the reference isodose volume) is 120 cc, then the conformity index is calculated to be 1.20, which describes there is 20% volume outside PTV receiving the prescribed dose.
Patient specific quality assurance
Patient specific quality assurances for DIBH-SBRT and FB-SBRT plans (total 20 plans) were performed using I'mRT MatriXX 2-dimensional ion chamber array (Scanditronix Wellhofer, Freiburg, Germany). The fluence were measured using the I'mrt matrix attached to the linear accelerator head using the gantry mount with 5 cm of slab phantom above and below the detector to enable the buildup and backscatter radiation. With the same geometry we created the Eclipse TPS predicted fluence for all the patients. The TPS predicted fluence and the measured fluence from the machine were compared using the Omnipro IMRT software. All the 20 plans were compared between the TPS predicted and measured fluence using the gamma evaluation method with a acceptance criteria of 95% of the pixel within the region of interest has to pass 3% dose difference and 3 mm distance to agreement (DTA).
Treatment localization
All the DIBH-SBRT and FB-SBRT plans were added with three setup fields, two fields with orthogonal KV-KV images for 2D-2D bony match and the third field for the 3D-3D matching using CBCT. During the DIBH treatment localization, lower and upper threshold of the gated window was set as per the values documented during the CT simulation. DIBH gated KV-KV image were acquired and match with the planning CT digitally reconstructed radiograph (DRR), by enabling the PTV outline. Verified that KV images tumour shadows were within the PTV outline in the DRR. (Figure 7) .
The two patients treated with DIBH-SBRT target localization also verified using the breath hold gated CBCT option available with the TrueBeam Linear Accelerator. The breath hold gated CBCT gave us enough confident about the accuracy of the tumor immobilized in the set upper and lower threshold by visualizing the tumor within the planning PTV as shown in the Figure 8 .
Statistical analysis:
All the statistical data were presented in study as the mean followed by the standard deviation (x̄ ± σ x̄) . The DIBH-SBRT plans dosimetric data were compared with the FB-SBRT plans data using the paired sample t-test performed using the Microsoft Excel version 2010 with p value < 0.05 considered as significant.
Results and Discussion

ITV and PTV volume
The mean followed by standard deviation (x̄ ± σ x̄) of DIBH-ITV and DIBH -PTV volume (cc) of all the patients were 51.29 ± 47.13 (range: 5.40 -131.70) and 92.01 ± 76.62 (range: 15.60 -246.30), whereas FB -ITV and FB -PTV volume were 74.42 ± 69.06 (range: 6.40 -211.50) and 112.66 ± 94.20 (range: 18.50 -323.30). We found that mean FB-ITV of all the patients were 1.45 times of DIBH-ITV and FB-PTV were 1.22 times larger than the DIBH-PTV. The volume variation of ITV and PTV between the two techniques were illustrated in the Figure 9 .The reductions of the ITV in the DIBH datasets were mainly due to immobilize the target within the gated upper and lower threshold window.
Conformity index and homogeneity index for PTV
The treatment plan quality of the DIBH-SBRT and FB-SBRT techniques were compared using the dose homogeneity index (HI) and dose conformity index (CI) using the Equation 1 and 2. The calculated dose homogeneity and conformity index between the two techniques were listed in Table 2 . The mean followed by standard deviation (x̄ ± σ x̄) of CI in the DIBH-SBRT and FB-SBRT plans were 1.22 ± 0.09 and 1.21 ± 0.09, HI for the the DIBH-SBRT and FB-SBRT plans were 0.17 ± 0.03 and 0.13 ± 0.02. 
Normal tissue (Body)
The dose comparison of the whole body low dose and high dose volumes for the DIBH-SBRT and FB-SBRT were listed in the Table 3 
Ipsilateral Lung
The dosimetric comparison parameters of the ipsilateral lung were tabulated in the Figure 11 . The x̄ ± σ x̄ of ipsilateral lung mean dose for DIBH-SBRT and FB-SBRT plans were 7.48 ± 3.57 and 10.23 ± 4.58 respectively, with a mean reduction of 36.84% in the DIBH-SBRT and they were highly statistical significant (p value 0.00).
Contralateral Lung
We have not observed any high dose volume in the contralateral lung. The dosimetric comparisons of both the techniques for the contralateral lung were listed in the Table 3 . The x̄ ± σ x̄ represented in percentage of volume (%) for DIBH-SBRT plans were V 5 (17.27±10.36) and V 10 (1.29 ± 0.79) and whereas for FB-SBRT plans were V 5 (19.47 ±14.87) and V 10 (2.31 ± 1.31).The DIBH-SBRT plans show a mean reduction of 12.73% in V 5 and 78.75% in V 10 compared to the FB-SBRT plans. The mean (x̄ ± σ x̄) dose (Gy) of the contralateral lung for the DIBH-SBRT and FB-SBRT were 2.09 ± 0.89 and 2.41 ± 1.14 with a mean reduction of 15.21% and they were statistical significant (p value 0.08). The dose volume histogram comparison of contralateral lung for a patient between DIBH-SBRT and FB-SBRT plans is shown in the Figure 11 .
Esophagus
Since all the patients included in this study were peripheral tumors, we have not observed any high dose volume in the esophagus. The dosimetric comparisons of both the techniques for the esophagus were listed in the 
Pulmonary Trunk
As the pulmonary trunk is a midline structure the high dose volumes were not found, only the low dose volumes V 5 , V 10, V 20 , V 30 and the mean dose (Gy) were listed for the DIBH-SBRT and FB-SBRT in the Table 3 . The x̄ ± σ x̄ of the pulmonary trunk were V 5 
Heart
The dosimetric parameters between the DIBH-SBRT and FB-SBRT plans were listed in the Table 3 . The x̄ ± σ x̄ represented in the dose (Gy) for the heart in DIBH-SBRT (4.23 ± 2.89) and FB-SBRT 
Main bronchus + Carina
The low dose volumes V 5 , V 10, V 20 , V 30 and the mean dose (Gy) of the main bronchus + carina were listed for the DIBH-SBRT and FB-SBRT in the 
Spinal cord
The dosimetric parameters V 5 , V 10 , mean dose and maximum doses between the DIBH-SBRT and FB-SBRT were listed in the Table 3 
Patient specific quality assurance results
Patient specific quality assurance for all the DIBH-SBRT and FB-SBRT plans (total 20 plans) were performed using I'mRT MatriXX 2-dimensional ion chamber (Scanditronix Wellhofer, Freiburg, Germany). The treatment planning system predicted fluence and the machine delivered fluence were evaluated using gamma evaluation criteria of 3mm DTA and 3% delta dose difference. All the twenty plans passed the criteria, the mean percentage (x̄ ± σ x̄) pixel passed in DIBH-SBRT plans were 97.3 ± 1.65, whereas FB-SBRT plans were 97.7 ± 1.82. This result concludes that TPS predicted fluence and the machine delivered fluence for all the twenty plans are within the acceptable tolerance.
Discussion
Two of ten patients received DIBH-SBRT comfortably during the treatment course; the gated DIBH CBCT shows great confidence in the tumor localization during the treatment delivery. The DIBH mean followed by standard deviation (x̄ ± σ x̄) of the right lung and left lung volume (cc) were 1939. [9] , conducted a non-standardized multicenter study which includes 401 patients comparing the DIBH and FB datasets, which resulted in the PTV volume (cc) of the DIBH was 282 ± 176 and FB was 360 ± 232 respectively (p value 0.00001). This study shows that the DIBH-PTV was 1.28 times larger than FB-PTV, which is comparable to our study.
We found that the increase in the PTV volume in the FB-SBRT compare to the DIBH-SBRT, FB-SBRT resulted in the higher dose to the lung and the critical structures. In DIBH-SBRT the mean heart dose was reduced by 11.98% and V20 by 28.31% (both the mean dose and V20 shows statistical significance) compare to the FB-SBRT. Ipsilateral lung for the DIBH-SBRT plans shows a mean reduction of 36.84% in mean dose, 46.21% in V20 and 76.12% in the V40 compare to the FB-SBRT plans. In this study we have not removed the PTV from the ipsilateral lung volume, hence compare to the other studies higher mean dose were documented. The mean conformity index and the homogeneity index of the both DIBH-SBRT and FB-SBRT plans were comparable, which shows both the techniques on target dose confirmation and dose homogeneity were similar.
All the patients included in this study were peripheral lung tumors; hence the doses to the middle critical structures were comparatively less. The mean doses of esophagus, pulmonary trunk and main bronchus + carina in DIBH-SBRT were 22.02%, 34.38% and 13.98% less compare to the FB-SBRT plans.
DIBH CT images characterizes a perfect absence of motion artifacts due to the nature of the breath hold CT data acquisition, which resulted in superior target boundary definition compare to the FB scans. To practice DIBH based SBRT, target re-localization during the treatment is an important component. In this study we had verified the relocalization during the treatment by gated DIBH KV -KV imaging with the overlay of the PTV in the DRR and a gated DIBH CBCT to verify the target position. Gated DIBH CBCT provides enough confidence about the DIBH-SBRT technique delivery accuracy; hence to practice DIBH-SBRT we need a strong image guidance tool to validate the treatment relocalization of the target.
We found that there is considerable amount of tumor motion within the upper and lower threshold of the DIBH scans; hence it is advisable to perform at-least three DIBH scans during the CT simulation with the same Dicom origin and Boolean the target volume to form an ITV. This will avoid a lot of residual error in re-localization during the treatment delivery.
In this work, we have treated two patients using DIBH based SBRT and the compliance of both the patients from the CTsimulation, treatment position verification to treatment delivery completion was satisfactory. We need to be careful in the patient selection and patient's compliance to proceed with DIBH based SBRT.
Conclusion
DIBH-SBRT plans are much superior due to smaller PTV due to its capability of immobilizing the target motion during the treatment within the threshold window. In this study we also found that the DIBH based SBRT significantly reduces the doses to the ipsilateral lung due to lung inflation, which will results in less lung toxicity compare to the FB based SBRT. We need well equipped advanced CT simulator with gating system and image guidance tool to practice safe DIBH based SBRT treatment.
